Tsingke Biotech Showcases Innovations in Oligonucleotide Synthesis at TIDES USA 2025 Tsingke Biotech exhibited its advanced oligonucleotide synthesis capabilities at TIDES USA 2025, emphasizing innovations in therapeutic production.

Tsingke Biotech Showcases Innovations in Oligonucleotide Synthesis at TIDES USA 2025 #USA #San_Diego #Oligonucleotide_Synthesis #Tsingke_Biotech #GMP_Production